衰弱与肝切除术后围手术期结局的关联:一项全国性研究
该回顾性队列研究基于2012至2019年美国全国住院患者样本,纳入≥65岁接受择期肝切除术的老年人,以Johns Hopkins调整临床组衰弱定义指标识别衰弱。结果显示衰弱与死亡率、围手术期并发症、住院时间和费用增加独立相关,但高手术量中心可减弱衰弱相关死亡率。
要点
- 衰弱与肝切除术后死亡风险独立相关(AOR 2.9,95%CI 2.0-4.3)。
- 衰弱与围手术期并发症风险独立相关(AOR 2.9,95%CI 2.4-3.4)。
- 高肝切除手术量中心可减弱衰弱相关死亡率。
核心结论
- 衰弱与肝切除术后较差的临床和经济结局相关,但高手术量中心衰弱相关死亡率不那么明显。
研究设计与样本
- 回顾性队列研究,纳入2012至2019年美国全国住院患者样本中所有≥65岁接受择期肝切除术的老年人。
主要发现
- 在约40735例接受大范围肝切除术的患者中,9.0%被判定为衰弱。
- 多变量调整后,衰弱与死亡率增加相关(AOR 2.9;95%CI 2.0-4.3;P < .001)。
- 衰弱与围手术期并发症增加相关(AOR 2.9;95%CI 2.4-3.4;P < .001)。
- 衰弱患者风险调整后住院时间更长(14.2 vs 6.7天,P < .001),住院费用更高($55,100 vs $29,300,P < .001)。
- 衰弱对死亡率的边际效应随手术量增加而减弱。
临床怎么用
- 基于编码的工具如Johns Hopkins调整临床组可从电子病历中识别可能受益于进一步老年评估和靶向治疗的患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Risk of mortality and major comorbidity remains high following hepatic resection. Given recent advancements in nonsurgical techniques to control hepatic malignancy, accurate assessment of surgical candidates, especially those considered frail, has become imperative. The present study aimed to characterize the impact of frailty on clinical and financial outcomes following hepatic resection in older individuals. DESIGN: Retrospective cohort study. SETTING AND PARTICIPANTS: All older adults (≥65 years) undergoing elective hepatic resection were identified from the 2012 to 2019 National Inpatient Sample. METHODS: Frailty was defined by using the Johns Hopkins Adjusted Clinical Groups frailty-defining diagnosis indicator. Multivariable regression models were developed to assess the independent association of frailty with mortality, perioperative complications, and resource utilization. Marginal effects were tabulated to assess the impact of hospital volume on frailty-associated mortality. RESULTS: Of an estimated 40,735 patients undergoing major hepatic resection, 9.0% were considered frail. After multivariable adjustment, frailty was associated with increased odds of mortality (adjusted odds ratio [AOR] 2.9; 95% confidence interval [CI] 2.0-4.3; P < .001) and perioperative complication (AOR 2.9; 95% CI 2.4-3.4; P < .001). Furthermore, frail patients incurred longer risk-adjusted length of stay (14.2 vs 6.7 days, P < .001) and greater hospitalization costs ($55,100 vs $29,300, P < .001). In assessing the impact of institutional expertise on perioperative outcomes, the marginal effect of frailty on mortality became less pronounced with increasing operative volume. CONCLUSIONS AND IMPLICATIONS: As the population of the United States continues to age, surgeons are increasingly likely to encounter candidates for major hepatic resection who are frail. The present study associated frailty with inferior clinical and financial outcomes; however, frailty-associated mortality became less pronounced at centers with high hepatic resection operative volume. Coding-based instruments, such as the Johns Hopkins Adjusted Clinical Groups, may identify patients from electronic medical records who may benefit from further geriatric assessment and targeted treatments.
引用
- Madrigal J, Hadaya J, Lee C, et al. Association of Frailty with Perioperative Outcomes Following Hepatic Resection: A National Study. J Am Med Dir Assoc. 2022. PMID: 35304129. doi:10.1016/j.jamda.2022.02.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。